Sergio Borgia

2.2k total citations
27 papers, 670 citations indexed

About

Sergio Borgia is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Sergio Borgia has authored 27 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Sergio Borgia's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Antibiotic Resistance in Bacteria (6 papers). Sergio Borgia is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Antibiotic Resistance in Bacteria (6 papers). Sergio Borgia collaborates with scholars based in Canada, United States and Italy. Sergio Borgia's co-authors include Donald E. Low, Stephen D. Shafran, Stephen Betschel, Evguenia S. Svarovskaia, Robert H. Hyland, Bandita Parhy, Charlotte Hedskog, Hongmei Mo, Joyce C. S. de Azavedo and Neil L. Barg and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Sergio Borgia

24 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Borgia Canada 11 389 317 224 127 113 27 670
F. Eb France 14 212 0.5× 119 0.4× 115 0.5× 28 0.2× 99 0.9× 32 528
Krispin Hajkowicz Australia 14 434 1.1× 95 0.3× 358 1.6× 65 0.5× 72 0.6× 33 669
Levent Görenek Türkiye 14 270 0.7× 91 0.3× 117 0.5× 69 0.5× 37 0.3× 42 554
Nurgül Ceran Türkiye 15 239 0.6× 43 0.1× 142 0.6× 38 0.3× 66 0.6× 28 503
Mohamed S. Ali Sudan 14 67 0.2× 97 0.3× 81 0.4× 93 0.7× 55 0.5× 31 522
Mojgan Mamani Iran 14 298 0.8× 57 0.2× 113 0.5× 40 0.3× 38 0.3× 45 556
Süheyla Serin Senger Türkiye 11 369 0.9× 25 0.1× 93 0.4× 31 0.2× 132 1.2× 27 543
Azucena Rodríguez-Guardado Spain 14 239 0.6× 22 0.1× 109 0.5× 178 1.4× 167 1.5× 53 628
Sahar Althawadi Saudi Arabia 16 267 0.7× 15 0.0× 394 1.8× 52 0.4× 177 1.6× 57 752
Dilek Çolak Türkiye 13 238 0.6× 65 0.2× 293 1.3× 98 0.8× 45 0.4× 65 523

Countries citing papers authored by Sergio Borgia

Since Specialization
Citations

This map shows the geographic impact of Sergio Borgia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Borgia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Borgia more than expected).

Fields of papers citing papers by Sergio Borgia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Borgia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Borgia. The network helps show where Sergio Borgia may publish in the future.

Co-authorship network of co-authors of Sergio Borgia

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Borgia. A scholar is included among the top collaborators of Sergio Borgia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Borgia. Sergio Borgia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webster, Duncan, Chris Fraser, Sergio Borgia, et al.. (2025). Resistance‐Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC‐CANUHC Analysis. Journal of Viral Hepatitis. 32(2). e14058–e14058.
2.
Zhanel, George G., Melanie Baxter, Sergio Borgia, et al.. (2024). How is ceftobiprole used in Canada: the CLEAR study final results. Expert Review of Anti-infective Therapy. 22(8). 681–688. 4 indexed citations
3.
Zhanel, George G., Melanie Baxter, Yazdan Mirzanejad, et al.. (2024). Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry. Expert Review of Anti-infective Therapy. 22(12). 1221–1228. 1 indexed citations
4.
Jamal, Alainna, Nathalie Tijet, Allison McGeer, et al.. (2023). 2468. The Genomic Epidemiology of Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada, 2016. Open Forum Infectious Diseases. 10(Supplement_2).
5.
Zhanel, George G., Melanie Baxter, Carlos Cervera, et al.. (2021). Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry. Journal of Global Antimicrobial Resistance. 25. 346–350. 10 indexed citations
6.
7.
Jamal, Alainna, Angel X. Li, Deborah Morrison, et al.. (2021). Standard versus combined chemical, mechanical, and heat decontamination of hospital drains harboring carbapenemase-producing organisms (CPOs): A randomized controlled trial. Infection Control and Hospital Epidemiology. 42(10). 1275–1278. 6 indexed citations
8.
Zhanel, George G., Melanie Baxter, Sergio Borgia, et al.. (2021). Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry. Journal of Global Antimicrobial Resistance. 24. 335–339. 21 indexed citations
9.
Vachon, Marie-Louise, Alexander Wong, Brian Conway, et al.. (2021). Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis. PubMed. 4(3). 283–291. 3 indexed citations
10.
Cooper, Curtis, Sergio Borgia, Marie-Louise Vachon, et al.. (2021). Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry. Clinical Infectious Diseases. 72(11). e799–e805. 13 indexed citations
11.
Cooper, Curtis, Daniel Read, Marie-Louise Vachon, et al.. (2020). Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants. BMC Public Health. 20(1). 1345–1345. 7 indexed citations
12.
Jamal, Alainna, Sergio Borgia, Jennie Johnstone, et al.. (2019). Infection prevention and control practices related to carbapenemase-producing Enterobacteriaceae (CPE) in acute-care hospitals in Ontario, Canada. Infection Control and Hospital Epidemiology. 40(9). 1006–1012. 15 indexed citations
13.
Jamal, Alainna, Kevin A. Brown, Kevin Katz, et al.. (2019). 1228. Risk Factors for Contamination with Carbapenemase-Producing Enterobacteriales (CPE) in Exposed Hospital Drains in Ontario, Canada. Open Forum Infectious Diseases. 6(Supplement_2). S441–S441. 1 indexed citations
14.
Cooper, Curtis, Marie-Louise Vachon, Brian Conway, et al.. (2019). THU-393-HCV infection in Canadian immigrants: Characteristics and treatment outcomes of the CANUHC cohort. Journal of Hepatology. 70(1). e328–e328. 1 indexed citations
15.
Borgia, Sergio, Charlotte Hedskog, Bandita Parhy, et al.. (2018). Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes. The Journal of Infectious Diseases. 218(11). 1722–1729. 214 indexed citations
16.
Borgia, Sergio, Denyse Richardson, Alireza Eshaghi, et al.. (2012). Outbreak of Carbapenem-Resistant Enterobacteriaceae Containing blaNDM-1, Ontario, Canada. Clinical Infectious Diseases. 55(11). e109–e117. 80 indexed citations
17.
Borgia, Sergio, et al.. (2011). Brucellosis in a returned traveller. Canadian Medical Association Journal. 183(10). E690–E692. 10 indexed citations
18.
Borgia, Sergio, Jeffrey Fuller, Alicia Sarabia, & Philippe El‐Helou. (2006). Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Medical Mycology. 44(7). 659–664. 37 indexed citations
19.
Borgia, Sergio, et al.. (2001). Group A Streptococcal Sepsis Secondary to Peritonitis and Acute Pelvic Inflammatory Disease. European Journal of Clinical Microbiology & Infectious Diseases. 20(6). 437–439. 15 indexed citations
20.
Borgia, Sergio, Stephen Betschel, Donald E. Low, & Joyce C. de Azavedo. (1997). Cloning of a Chromosomal Region Responsible for Streptolysin S Production in Streptococcus pyogenes. Advances in experimental medicine and biology. 418. 733–736. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Eb Breakdown of academic impact, for papers by Krispin Hajkowicz Breakdown of academic impact, for papers by Levent Görenek Breakdown of academic impact, for papers by Nurgül Ceran Breakdown of academic impact, for papers by Mohamed S. Ali Breakdown of academic impact, for papers by Mojgan Mamani Breakdown of academic impact, for papers by Süheyla Serin Senger Breakdown of academic impact, for papers by Azucena Rodríguez-Guardado Breakdown of academic impact, for papers by Sahar Althawadi Breakdown of academic impact, for papers by Dilek Çolak
Rankless by CCL
2026